Legend Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.30 M
- Revenue Growth 9.62%
- Profit Growth -36.97%
- Ebitda -28.49%
- Net Worth 12.17%
- Total Assets 14.40%
About Legend Remedies
Legend Remedies Private Limited (LRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 March 1997 and has a history of 27 years and 11 months. Its registered office is in Surat, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.30 M.
Deepali Desai and Ujjal Ghosal serve as directors at the Company.
Company Details
- Location Surat, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ1997PTC031917
- Company No.
031917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Legend Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujjal Ghosal  | Managing Director | 28-Aug-2003 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepali Desai | Director | 17-Mar-1997 | Current |
Financial Performance of Legend Remedies.
Legend Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.62% increase. The company also saw a substantial fall in profitability, with a 36.97% decrease in profit. The company's net worth Soared by an impressive increase of 12.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Legend Remedies?
In 2023, Legend Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.30 M
₹0
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 0.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2017 | Standard Chartered Bank | ₹9.30 M | Open |
How Many Employees Work at Legend Remedies?
Legend Remedies has a workforce of 68 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Legend Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legend Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
